The accompanying notes are an integral part of these unaudited consolidated financial statements.
The accompanying notes are an integral part of these unaudited consolidated financial statements.
The accompanying notes are an integral part of these unaudited consolidated financial statements.
The accompanying notes are an integral part of these unaudited consolidated financial statements.
The accompanying Consolidated Balance Sheet as of September 30, 2017 was derived from the audited annual consolidated financial statements as of the period then ended.
The Company enters into foreign exchange contracts to reduce its exposure to currency fluctuations.
The forward contract arrangements that the Company enters into typically mature in three months or less.
These transactions do not qualify for hedge accounting.
Foreign exchange contract assets and liabilities are measured and reported at fair value based on observable market inputs and classified within Level 2 of the fair value hierarchy due to a lack of an active market for these contracts.
In March 2016, the FASB issued an amendment to the accounting guidance to simplify accounting for share-based payment awards issued to employees.Item 2.
·    Overview.
This section provides an analysis of our financial results for the three months ended December 31, 2017 compared to the three months ended December 31, 2016.
anticipated or unanticipated events.
Please refer to Note 4, “Acquisitions” in the Notes to the unaudited consolidated financial statements included in Item 1 "Consolidated Financial Statements" of this Quarterly Report on Form 10‑Q for further information on this transaction.
In fiscal year 2017, we launched BioStudies, a bioinformatics sample intelligence software platform that enables customers to manage their global samples.
Results of Operations- Revenue for the three months ended December 31, 2017 increased to $189.3 million, or by 18%, as compared to the corresponding period of the prior fiscal year.
Gross margin was 39.7% for the first quarter of fiscal year 2018 as compared to 35.6% for the first quarter of fiscal year 2017, which resulted in an increase in gross profit of $18.3 million.